How to taper off Cymbalta (duloxetine) after long-term use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper Off Cymbalta (Duloxetine) 60mg After Long-Term Use

Reduce duloxetine gradually by 30mg (to 30mg daily) for at least 1-2 weeks, then discontinue completely, monitoring closely for withdrawal symptoms and slowing the taper if needed. 1

Understanding Duloxetine Discontinuation

Duloxetine, like other serotonin-norepinephrine reuptake inhibitors (SNRIs), requires gradual tapering to minimize withdrawal symptoms. After more than 2 years of use at 60mg daily, your body has adapted to the medication's effects on serotonin and norepinephrine reuptake, making abrupt cessation problematic 1, 2.

FDA-Approved Tapering Approach

The FDA label for duloxetine explicitly states that "a gradual reduction in dosage rather than abrupt cessation is recommended whenever possible" 1. Common discontinuation symptoms include:

  • Dizziness and headache
  • Nausea, diarrhea, and vomiting
  • Paresthesia (tingling sensations)
  • Irritability and anxiety
  • Insomnia and fatigue
  • Hyperhidrosis (excessive sweating) 1

Recommended Tapering Protocol

Step 1: Initial Dose Reduction

  • Reduce from 60mg to 30mg once daily 1
  • Maintain this dose for at least 1-2 weeks before proceeding 2
  • The first dose reduction is critical—it must go well to predict tolerance for complete discontinuation 3

Step 2: Monitor for Withdrawal Symptoms

  • Assess for any discontinuation symptoms during the 30mg phase 1
  • If symptoms are mild and tolerable, proceed to complete cessation after 1-2 weeks 2
  • If symptoms are moderate to severe, extend the 30mg phase for several more weeks 2, 4

Step 3: Complete Discontinuation

  • After tolerating 30mg for the appropriate duration, discontinue completely 1
  • Continue monitoring for 1-2 weeks post-discontinuation 2

When to Slow the Taper Further

If you experience intolerable symptoms at any point:

  • Return to the previous dose that was well-tolerated 1
  • Wait until symptoms resolve completely
  • Resume tapering at a slower rate, potentially extending each phase to 2-4 weeks 2, 4
  • Some patients may benefit from an even more gradual approach, reducing by smaller increments over months 5, 4

The evidence shows that tapers of 2-4 weeks show minimal benefit over abrupt discontinuation for some patients, while others require much longer tapers extending over months 5. Since duloxetine has a relatively short half-life compared to some antidepressants, withdrawal symptoms can emerge more readily, necessitating careful attention to tapering speed 2.

Alternative Hyperbolic Tapering Approach

For patients who struggle with standard tapering, research suggests that hyperbolic (exponential) tapering may be more effective 5. This involves:

  • Reducing doses in a way that decreases the drug's biological effect linearly at receptor sites
  • Making progressively smaller dose reductions as you approach zero
  • Potentially using liquid formulations or compounded lower doses if available 5, 4

However, duloxetine is only available in 20mg, 30mg, and 60mg capsules, limiting this approach unless compounding is pursued 1.

Critical Pitfalls to Avoid

Never stop duloxetine abruptly after 2+ years of use—this significantly increases the risk of severe withdrawal symptoms 1, 2. The withdrawal syndrome can be mistaken for relapse of your original condition (depression, anxiety, pain), leading to unnecessary resumption of medication 2, 5.

Do not interpret all symptoms as relapse. Withdrawal symptoms typically:

  • Emerge within days of dose reduction or discontinuation
  • Are often physical (dizziness, nausea, paresthesias) in addition to psychological
  • Improve gradually over 1-2 weeks without medication reinstatement 2, 4

True relapse of the underlying condition typically:

  • Emerges more gradually over weeks
  • Consists primarily of the original psychiatric symptoms
  • Does not include prominent physical symptoms like electric shock sensations 2

Managing Withdrawal Symptoms

If withdrawal symptoms occur despite gradual tapering:

  • Reassure yourself that symptoms are usually transient and self-limiting 2
  • For mild symptoms, continue the taper with close monitoring 2
  • For moderate to severe symptoms, return to the previous dose and slow the taper 1, 2
  • Consider supportive measures: adequate sleep, hydration, light exercise 4
  • Avoid adding new medications to treat withdrawal symptoms unless absolutely necessary 2

Realistic Timeline Expectations

  • Minimum duration: 2-4 weeks total (1-2 weeks at 30mg, then discontinue) 1, 2
  • More conservative approach: 4-8 weeks (2-4 weeks at 30mg, then discontinue) 2, 5
  • For sensitive patients: Several months with smaller incremental reductions 5, 4

Research indicates that 8.9% of patients receive evidence of deliberate tapering in clinical practice, suggesting many patients successfully discontinue without extensive tapering 3. However, it's impossible to predict who will struggle, so a cautious approach is warranted 3, 4.

When to Seek Additional Help

Contact your prescriber immediately if you experience:

  • Severe or intolerable withdrawal symptoms despite slowing the taper 1
  • Suicidal thoughts or severe mood changes 1
  • Symptoms that persist beyond 2-3 weeks after complete discontinuation 2
  • Uncertainty about whether symptoms represent withdrawal versus relapse 2, 4

Your healthcare provider may consider temporarily returning to a higher dose and implementing an even more gradual taper, or addressing whether the underlying condition requires continued treatment 1, 4.

References

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

Antidepressant Tapering Is Not Routine But Could Be.

Journal of the American Board of Family Medicine : JABFM, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.